Literature DB >> 1490492

Pharmacokinetics of heptacaine, a novel potent local anaesthetic agent, after rectal administration to rats.

V Faberová1, M Durisová, T Trnovec, D Divisová.   

Abstract

The pharmacokinetics of heptacaine, N-(2-(2-heptyloxyphenylcarbamoyloxy)ethyl)-piperidinium chloride, a new long-acting potent carbanilate type local anaesthetic, proposed for local anaesthesia in complex treatment of hemorrhoids, was studied following its rectal administration to rats in the form of cocoa butter suppositories. The heptacaine plasma concentration, 0.0083% of dose/ml, peaked at 90 min post administration and the maximum rate of its bioavailability, 0.19% of dose/min, assessed by deconvolution, occurred 38 min post administration. The plasma elimination half-life of heptacaine was 133 min and its biological availability of 52% was comparable to other agents of the class.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1490492     DOI: 10.1007/BF03190150

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  9 in total

1.  Effect of local anaesthetics and pH: new aspects.

Authors:  S Stolc; T Stankovicová
Journal:  Drugs Exp Clin Res       Date:  1986

2.  Alkoxycarbanilic acid esters with high local anaesthetic activity.

Authors:  L Benes; A Borovanský; L Kopácová
Journal:  Arzneimittelforschung       Date:  1969-11

3.  N-[2-(2-Heptyloxyphenylcarbomoyloxy)-ethyl]-piperidinium chloride, heptacaine, a new local anaesthetic.

Authors:  J Cizmárik; A Borovanský; P Svec
Journal:  Pharmazie       Date:  1978-05       Impact factor: 1.267

4.  An algorithm and computer program for deconvolution in linear pharmacokinetics.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1980-10

5.  Rectal bioavailability of lidocaine in rats: absence of significant first-pass elimination.

Authors:  A G de Boer; D D Breimer; J Pronk; J M Gubbens-Stibbe
Journal:  J Pharm Sci       Date:  1980-07       Impact factor: 3.534

6.  Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolism.

Authors:  A G de Boer; D D Breimer; H Mattie; J Pronk; J M Gubbens-Stibbe
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

7.  Pharmacokinetics of the new local anaesthetic N-[2-(2-Heptyloxyphenylcarbamoyloxy)ethyl]piperidinium chloride in rats and mice.

Authors:  V Scasnár; Z Kállay; S Bezek; T Trnovec; M Durisovă
Journal:  Arzneimittelforschung       Date:  1987-07

8.  [Basic trans- and cis-cyclohexyl esters of substituted alkoxycarbanilic acids. XLI. Local anesthetics].

Authors:  L Benes; A Borovanský; L Kopácová
Journal:  Arch Pharm (Weinheim)       Date:  1972-09       Impact factor: 3.751

9.  Antiarrhythmic activity of heptacaine and some of its derivatives.

Authors:  J Kozlovský; J Cizmárik; M Pesák; F Inczinger; A Borovanský
Journal:  Arzneimittelforschung       Date:  1982
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.